Temazepam (Euhypnos®) as a Hypnotic: A Twelve-Week Trial in General Practice

Publisher Website
Google Scholar
Abstract
One hundred and forty-seven patients requiring a hypnotic, took soft gelatine capsules containing 10 mg temazepam (Euhypnos®), 10-30 mg at night, for up to twelve weeks. One hundred and thirty-three patients (90·5%) completed twelve weeks on drug. Hypnotic performance was rated Good or Very Good in 90% of their assessments and 93·2% of the assessments recorded no hangover effect. Adverse reactions were occasional headaches and nausea. There were no drug-related accidents. One hundred and forty-two patients (96·6%) said there was no adverse effect on their work. Seven patients who did not complete twelve weeks resumed normal sleep patterns and had no further need for hypnotics.

This publication has 2 references indexed in Scilit: